Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Biedermann

Showing results (1-10 of 135) with videos related to

Pageof 14
Sort By:
Journal of the European Academy of Dermatology and Venereology : JEADV|July 19, 2016
To remember: Radiotherapy - a successful treatment for early Dupuytren's diseaseB Eberlein, T Biedermann
Journal of the European Academy of Dermatology and Venereology : JEADV|December 17, 2017
Pityriasis rubra pilaris: algorithms for diagnosis and treatmentS Roenneberg, T Biedermann
Dermatologie (Heidelberg, Germany)|August 4, 2022
[Atopic dermatitis-Spoilt for choice or entrance into a personalized treatment?]T Biedermann, T Werfel
Ernst Schering Research Foundation Workshop|November 6, 2004
Pro- and anti-inflammatory effects of IL-4: from studies in mice to therapy of autoimmune diseases in humansT Biedermann, M Röcken
Allergy|November 23, 2013
Anaphylaxis: opportunities of stratified medicine for diagnosis and risk assessmentF Wölbing, T Biedermann
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|February 28, 2018
[Atopic eczema]A Wollenberg, T Biedermann
Journal of the European Academy of Dermatology and Venereology : JEADV|August 21, 2021
Successful treatment of disseminated superficial actinic porokeratosis with topical 2% cholesterol/ 2% lovastatin cream: a case series with 7 patientsD Tomsitz, T Biedermann
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|May 1, 2012
[Delayed appearance of symptoms in immediate hypersensitivity: type I sensitization to galactose-α-1,3-galactose]T Biedermann, M Röcken
Springer Seminars in Immunopathology|February 10, 2000
Th1/Th2 balance in atopyT Biedermann, M Röcken
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|February 18, 2018
[Microbiome, atopic eczema and blockade of type 2 immunity]M Köberle, T Biedermann
Pageof 14

Showing results (1-10 of 135) with videos related to

Sort By:
Pageof 14
Journal of the European Academy of Dermatology and Venereology : JEADV|July 19, 2016
To remember: Radiotherapy - a successful treatment for early Dupuytren's diseaseB Eberlein, T Biedermann
Journal of the European Academy of Dermatology and Venereology : JEADV|December 17, 2017
Pityriasis rubra pilaris: algorithms for diagnosis and treatmentS Roenneberg, T Biedermann
Dermatologie (Heidelberg, Germany)|August 4, 2022
[Atopic dermatitis-Spoilt for choice or entrance into a personalized treatment?]T Biedermann, T Werfel
Ernst Schering Research Foundation Workshop|November 6, 2004
Pro- and anti-inflammatory effects of IL-4: from studies in mice to therapy of autoimmune diseases in humansT Biedermann, M Röcken
Allergy|November 23, 2013
Anaphylaxis: opportunities of stratified medicine for diagnosis and risk assessmentF Wölbing, T Biedermann
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|February 28, 2018
[Atopic eczema]A Wollenberg, T Biedermann
Journal of the European Academy of Dermatology and Venereology : JEADV|August 21, 2021
Successful treatment of disseminated superficial actinic porokeratosis with topical 2% cholesterol/ 2% lovastatin cream: a case series with 7 patientsD Tomsitz, T Biedermann
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|May 1, 2012
[Delayed appearance of symptoms in immediate hypersensitivity: type I sensitization to galactose-α-1,3-galactose]T Biedermann, M Röcken
Springer Seminars in Immunopathology|February 10, 2000
Th1/Th2 balance in atopyT Biedermann, M Röcken
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|February 18, 2018
[Microbiome, atopic eczema and blockade of type 2 immunity]M Köberle, T Biedermann
Pageof 14